Here at Mission BioCapital, we love working with entrepreneurs like you. We and our partner life science incubators are constantly developing new ways to provide a launchpad for world-changing science.

As biotech entrepreneurs, you have unique needs: You need lab space fitted with state-of-the-art research equipment; professional support staff who can manage everything from EH&S training to proper handling of biohazard waste; office space for meetings with your team and potential investors; and a vibrant, collaborative space in which to share ideas and expertise with other exciting life science companies.

You also need capital to pay for those critical early experiments, consultants, the rent, the insurance. You need leading-edge discovery and development services. You need legal advice and accounting expertise. 

You need advice on what those critical early experiments should be. You need perspective on defining a meaningful roadmap for an early-stage biotech company.

The Platinum Program was designed to meet all these needs! Together with our partners, we aim to find high-potential early-stage biomedical innovations powered by enthusiastic teams and back them for the best possible chance for success.

Our 2024 Platinum Program will award up to six winning startup-ups with:

• A guaranteed lab bench in one of Mission BioCapital’s affiliated incubators located in 13 cities in the U.S. and Europe
• Up to $500,000 per awardee
• Drug discovery services from Alloy Therapeutics to enable companies with a derisked pathway to lead candidate
• Legal advising on company incorporation, technology licenses, cap tables, etc. from Goodwin
• Day-to-day accounting support and finance services from van den Boom & Associates
• Strategic scientific and business development mentorship from experts across MBC’s corporate network, including sponsors Mission BioCapital, Lilly, OVI, and Alloy Therapeutics
• Biolab Masterclass 

If you have been selected as a finalist for the 2024 European Platinum Program, you will receive an email notifying you in August. Finalists will be required to virtually pitch to the Mission BioCapital partnership on August 7, 2024. Award decisions will be made thereafter. All applicants will receive an email notification about the conclusion of this year’s contest in September.

Thank you for your interest in the Mission BioCapital Platinum Program!

Note: If you have already applied and are based in Europe, your application is not affected by the new deadline. If you have already applied and not based in Europe, your application will follow the same timeline.